Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

CMV infection increases the risk of GvHD after bone marrow transplants.

The authors agree more research with proper control groups is needed to understand hair loss.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

The patient had paraneoplastic pemphigus without mucosal involvement.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Basal cell carcinoma cases are rising globally.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Atopy and altered T cell functions contribute to Alopecia Areata.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

The Fas/FasL pathway may play a role in alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

The nodule was a benign cutaneous lymphadenoma, not cancer, and was successfully removed.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Nanotechnology can improve tissue healing by controlling immune responses.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.